Laboratory tests in primary care · by Dr Solange Déplanque and Dr Michaël Rochoy

Treatment: lithium

Psychiatry and addiction medicine · Treatment monitoring · updated 2026-11-09

BioMG follows French guidelines. Adapt it to the guidelines and the tests available where you practise.

Frequency: In France, the lithium dispensing rate averaged 2.4 per 1 000 people aged 16 and over across areas of residence (0 to 6.6), based on national health insurance reimbursements 2006-2013; old data, dispensing rate and not a national headcount [1].

Pre-treatment tests

Fasting sample.

Fasting laboratory tests

Urine tests

Detailed explanation and international comparison (in French): read it in English (machine translation)

Starting lithium: first three months

Laboratory tests to be done in the morning, 12 h after the last lithium dose

to be done every week in the first month, then every month until the end of the 3rd month, i.e.

At the 3-month (12-week) tests, add

Detailed explanation and international comparison (in French): read it in English (machine translation)

Monitoring tests (every 6 months)

Laboratory tests to be done in the morning, 12 h after the last lithium dose

Detailed explanation and international comparison (in French): read it in English (machine translation)

Also consider

Do not order

Starting lithium with TERALITHE® 250mg

Laboratory tests to be done in the morning, 12 h after the last lithium dose

Detailed explanation and international comparison (in French): read it in English (machine translation)

Starting lithium with TERALITHE LP® 400mg (prolonged release)

Laboratory tests to be done in the morning, 12 h after the last lithium dose

Detailed explanation and international comparison (in French): read it in English (machine translation)

Situation at risk of overdose (dehydration, new drug)

Laboratory tests 5 to 7 days after the change (without delay if signs of overdose)

Detailed explanation and international comparison (in French): read it in English (machine translation)

Older person (60 years and over): monitoring

Fasting sample.

Every 3 to 6 months (serum lithium in the morning, 12 h after the last dose)

Every 6 to 12 months, fasting

Every year

Detailed explanation and international comparison (in French): read it in English (machine translation)

Sources (18)
  1. Geographical disparities in prescription practices of lithium and clozapine: a community-based study. Acta Psychiatr Scand 2016 (auteurs non vérifiés ; résumé lu via Europe PMC).
  2. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit TERALITHE 250 mg, comprimé sécable (rubriques 4.2 à 4.9), dernière mise à jour le 29/09/2026, consulté le 11 octobre 2026.
  3. Nederlandse Vereniging voor Psychiatrie (NVvP). Richtlijn Bipolaire stoornissen, module « Lithium bij bipolaire stoornis ». Publiée et jugée valide le 24 mars 2026.
  4. Nederlandse federatie voor Nefrologie. Richtlijn Renale bijwerkingen chronisch lithiumgebruik. Septembre 2013.
  5. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97-170.
  6. Shahraki RA, Meehan AD, Wallin G, Daskalakis K. Lithium-associated hyperparathyroidism: a systematic review of prevalence and surgical outcomes. Langenbecks Arch Surg. 2026;411(1).
  7. Haute Autorité de santé. ALD n° 23 : troubles bipolaires. Liste des actes et prestations, 2009.
  8. National Institute for Health and Care Excellence. Bipolar disorder: assessment and management. Clinical guideline CG185, 2014, mise à jour du 2 septembre 2025, recommandations 1.2.12 et 1.10.14 à 1.10.24.
  9. NHS Specialist Pharmacy Service. Lithium monitoring. Dernière mise à jour le 6 décembre 2024.
  10. Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale VersorgungsLeitlinie Unipolare Depression – Langfassung, Version 3.2, 2022 (révision de juillet 2023), AWMF-Register-Nr. nvl-005 (tableau 30).
  11. Department of Veterans Affairs, Department of Defense. VA/DoD Clinical Practice Guideline for Management of Bipolar Disorder. Version 2.0, mai 2023.
  12. ANSM, Base de données publique des médicaments. Résumé des caractéristiques du produit TERALITHE LP 400 mg, comprimé sécable à libération prolongée (rubrique 4.2), dernière mise à jour le 29/09/2026, consulté le 11 octobre 2026.
  13. Haute Autorité de santé. Prise en charge des hypothyroïdies chez l'adulte. Recommandation de bonne pratique, mars 2023 (§ 3.2.8).
  14. Malhi GS, Bell E, Outhred T, Berk M. Lithium therapy and its interactions. Aust Prescr. 2020;43(3):91-93.
  15. Kibirige D, Luzinda K, Ssekitoleko R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res. 2013;6(1):3.
  16. Assurance maladie. Nomenclature des actes de biologie médicale (NABM), version 105 : actes 1208 (TSH) et 0557 (lithium : lithiémie sérique ou érythrocytaire).
  17. Shulman KI, Almeida OP, Herrmann N, et al. Delphi survey of maintenance lithium treatment in older adults with bipolar disorder: an ISBD task force report. Bipolar Disord. 2019;21(2):117-123.
  18. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222, 29 juin 2022 (recommandations sur le lithium en association).